{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:51:20Z","timestamp":1792788680683,"version":"4.5.0"},"reference-count":40,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"FAPESP","award":["2024\/08982-1 (BLA), 2021\/14414-8 (JBJ), 2024\/17989-0 (TCCA), 2023\/16075-1 (DLO), 2024\/10306-4 (EA) e 2019\/16805-4 (GDN)"],"award-info":[{"award-number":["2024\/08982-1 (BLA), 2021\/14414-8 (JBJ), 2024\/17989-0 (TCCA), 2023\/16075-1 (DLO), 2024\/10306-4 (EA) e 2019\/16805-4 (GDN)"]}],"id":[{"id":"https:\/\/ror.org\/02ddkpn78","id-type":"ROR","asserted-by":"crossref"}]},{"name":"FAPESP","award":["303839\/2019-8 (GDN)"],"award-info":[{"award-number":["303839\/2019-8 (GDN)"]}],"id":[{"id":"https:\/\/ror.org\/02ddkpn78","id-type":"ROR","asserted-by":"crossref"}]},{"name":"FAPESP","award":["001 (GDN)"],"award-info":[{"award-number":["001 (GDN)"]}],"id":[{"id":"https:\/\/ror.org\/02ddkpn78","id-type":"ROR","asserted-by":"crossref"}]},{"name":"CNPq","award":["2024\/08982-1 (BLA), 2021\/14414-8 (JBJ), 2024\/17989-0 (TCCA), 2023\/16075-1 (DLO), 2024\/10306-4 (EA) e 2019\/16805-4 (GDN)"],"award-info":[{"award-number":["2024\/08982-1 (BLA), 2021\/14414-8 (JBJ), 2024\/17989-0 (TCCA), 2023\/16075-1 (DLO), 2024\/10306-4 (EA) e 2019\/16805-4 (GDN)"]}],"id":[{"id":"https:\/\/ror.org\/03swz6y49","id-type":"ROR","asserted-by":"crossref"}]},{"name":"CNPq","award":["303839\/2019-8 (GDN)"],"award-info":[{"award-number":["303839\/2019-8 (GDN)"]}],"id":[{"id":"https:\/\/ror.org\/03swz6y49","id-type":"ROR","asserted-by":"crossref"}]},{"name":"CNPq","award":["001 (GDN)"],"award-info":[{"award-number":["001 (GDN)"]}],"id":[{"id":"https:\/\/ror.org\/03swz6y49","id-type":"ROR","asserted-by":"crossref"}]},{"name":"CAPES","award":["2024\/08982-1 (BLA), 2021\/14414-8 (JBJ), 2024\/17989-0 (TCCA), 2023\/16075-1 (DLO), 2024\/10306-4 (EA) e 2019\/16805-4 (GDN)"],"award-info":[{"award-number":["2024\/08982-1 (BLA), 2021\/14414-8 (JBJ), 2024\/17989-0 (TCCA), 2023\/16075-1 (DLO), 2024\/10306-4 (EA) e 2019\/16805-4 (GDN)"]}]},{"name":"CAPES","award":["303839\/2019-8 (GDN)"],"award-info":[{"award-number":["303839\/2019-8 (GDN)"]}]},{"name":"CAPES","award":["001 (GDN)"],"award-info":[{"award-number":["001 (GDN)"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Braz J Med Biol Res"],"abstract":"<jats:p>6-Nitrodopamine (6-ND) released from isolated rat atria produces potent positive chronotropic actions. Direct negative chronotropic responses to some selective \u03b11-adrenoceptor (AR) antagonists like prazosin have been reported. Since \u03b11-AR antagonists inhibit 6-ND-induced smooth muscle contractions, we have hypothesized that negative chronotropism induced by \u03b11-AR antagonists reflects 6-ND blockade. This study investigated whether selective \u03b11-AR antagonists affect 6-ND-induced positive chronotropism in isolated rat atria. Alfuzosin at 10 nM did not affect the atrial rate, but at 100 nM, it significantly reduced the atrial rate. This effect was not observed in L-NAME (100 mM)-treated preparations or in atria from rats chronically treated with L-NAME. Alfuzosin (100 nM) significantly reduced the 6-ND-induced positive chronotropism without affecting the chronotropic responses to noradrenaline, adrenaline, or dopamine. Similar results were obtained with doxazosin (1-10 nM), tamsulosin (10-100 nM), and prazosin (1-10 nM). Isoprenaline induced concentration-dependent increases in atrial rate, which were not significantly affected by any of these \u03b11-AR antagonists. The results demonstrated that \u03b11-AR antagonists reduced atrial basal rate only at concentrations affecting the positive chronotropic effect of 6-ND, and this reduction was not observed when NO synthesis was blocked, indicating that the negative chronotropic effect may involve 6-ND receptor blockade.<\/jats:p>","DOI":"10.1590\/1414-431x2026e15550","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:00:12Z","timestamp":1791802812000},"source":"Crossref","is-referenced-by-count":0,"title":["Alpha1-adrenoceptor antagonists block the positive chronotropic effect of 6-nitrodopamine in the isolated rat right atrium"],"prefix":"10.1590","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1509-149X","authenticated-orcid":false,"given":"B.L.","family":"Alves","sequence":"first","affiliation":[{"name":"Universidade Estadual de Campinas","place":["Campinas, SP, Brasil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9564-651X","authenticated-orcid":false,"given":"A.J.S.","family":"Niederauer","sequence":"additional","affiliation":[{"name":"Universidade Estadual de Campinas","place":["Campinas, SP, Brasil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0250-8468","authenticated-orcid":false,"given":"J.","family":"Britto-J\u00fanior","sequence":"additional","affiliation":[{"name":"Universidade Estadual de Campinas","place":["Campinas, SP, Brasil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4521-6241","authenticated-orcid":false,"given":"J.F.","family":"Sobanski","sequence":"additional","affiliation":[{"name":"Universidade Estadual de Campinas","place":["Campinas, SP, Brasil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0641-3355","authenticated-orcid":false,"given":"T.C.C. de","family":"Assis","sequence":"additional","affiliation":[{"name":"Universidade Estadual de Campinas","place":["Campinas, SP, Brasil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7461-1600","authenticated-orcid":false,"given":"D.L.","family":"Oliveira","sequence":"additional","affiliation":[{"name":"Universidade Estadual de Campinas","place":["Campinas, SP, Brasil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0030-6542","authenticated-orcid":false,"given":"G.","family":"Said","sequence":"additional","affiliation":[{"name":"Universidade Estadual de Campinas","place":["Campinas, SP, Brasil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8700-5709","authenticated-orcid":false,"given":"G.D.","family":"Mendes","sequence":"additional","affiliation":[{"name":"Departamento de Farmacologia","place":["Campinas, SP, Brasil"]},{"name":"Universidade Metropolitana de Santos","place":["Santos, SP, Brasil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6627-3448","authenticated-orcid":false,"given":"A.S.","family":"Pupo","sequence":"additional","affiliation":[{"name":"Instituto de Bioci\u00eancias de Botucatu, Universidade Estadual Paulista","place":["Botucatu, SP, Brasil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Marcondes","sequence":"additional","affiliation":[{"name":"Universidade Estadual de Campinas","place":["Campinas, SP, Brasil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2201-8247","authenticated-orcid":false,"given":"E.","family":"Antunes","sequence":"additional","affiliation":[{"name":"Universidade Estadual de Campinas","place":["Campinas, SP, Brasil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4346-7941","authenticated-orcid":false,"given":"G. De","family":"Nucci","sequence":"additional","affiliation":[{"name":"Universidade Estadual de Campinas","place":["Campinas, SP, Brasil"]},{"name":"Departamento de Farmacologia","place":["Campinas, SP, Brasil"]},{"name":"Universidade Metropolitana de Santos","place":["Santos, SP, Brasil"]},{"name":"Instituto de Ci\u00eancias Biom\u00e9dicas, Universidade de S\u00e3o Paulo","place":["S\u00e3o Paulo, SP, Brasil"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2026]]},"reference":[{"issue":"1","key":"ref1","first-page":"44","article-title":"Endothelium-derived dopamine and 6-nitrodopamine in the cardiovascular system","volume":"39","author":"Zatz R","year":"2024","journal-title":"Physiology (Bethesda)"},{"issue":"6","key":"ref2","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s00210-023-02394-9","article-title":"Investigation on the positive chronotropic action of 6-nitrodopamine in the rat isolated atria","volume":"396","author":"Britto-J\u00fanior J","year":"2023","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"10","key":"ref3","first-page":"2012","article-title":"6-Nitrodopamine is the most potent endogenous positive inotropic agent in the isolated rat heart","volume":"13","author":"Britto-J\u00fanior J","year":"2023","journal-title":"Life (Basel)"},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1007\/s00210-024-03463-3","article-title":"The negative chronotropic effects of (\u00b1)-propranolol and (\u00b1)-4-NO2-propranolol in the rat isolated right atrium are due to blockade of the 6-nitrodopamine receptor","volume":"398","author":"Oliveira DL","year":"2024","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"174716","DOI":"10.1016\/j.ejphar.2021.174716","article-title":"Alpha1-adrenergic antagonists block 6-nitrodopamine contractions in the rat isolated epididymal vas deferens","volume":"915","author":"Britto-J\u00fanior J","year":"2022","journal-title":"Eur J Pharmacol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"122695","DOI":"10.1016\/j.lfs.2024.122695","article-title":"Epithelium-derived 6-nitrodopamine modulates noradrenaline-induced contractions in human seminal vesicles","volume":"348","author":"Britto-J\u00fanior J","year":"2024","journal-title":"Life Sci"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.niox.2024.10.010","article-title":"Neurogenic-derived 6-nitrodopamine is the most potent endogenous modulator of mouse urinary bladder relaxation","volume":"153","author":"de Oliveira MG","year":"2024","journal-title":"Nitric Oxide"},{"issue":"6","key":"ref8","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1111\/andr.13585","article-title":"6-Nitrodopamine is an endogenous mediator of rabbit corpus cavernosum relaxation","volume":"12","author":"Lima AT","year":"2024","journal-title":"Andrology"},{"issue":"5","key":"ref9","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1007\/s00210-023-02805-x","article-title":"Alpha1-adrenergic blockers selectively antagonize contractions induced by 6-nitrodopamine in the human vas deferens","volume":"397","author":"Britto-J\u00fanior J","year":"2024","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"16","key":"ref10","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0024-3205(96)00650-9","article-title":"Myocardial alpha1-adrenoceptor: inotropic effect and physiologic and pathologic implications","volume":"60","author":"Li K","year":"1997","journal-title":"Life Sci"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00005344-199807000-00018","article-title":"Distribution of alpha1-adrenergic receptor mRNA species in rat heart","volume":"32","author":"Wolff DW","year":"1998","journal-title":"J Cardiovasc Pharmacol"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0022-3565(24)35173-0","article-title":"Alpha1-adrenoceptor subtypes mediating inotropic responses in rat heart","volume":"291","author":"Zhang YY","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejphar.2018.08.038","article-title":"Alpha1B-adrenoceptor-mediated positive inotropic and positive chronotropic actions in the mouse atrium","volume":"839","author":"Zhang S","year":"2018","journal-title":"Eur J Pharmacol"},{"issue":"Suppl 1","key":"ref14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF02650344","article-title":"On the mechanism of positive inotropic effects of alpha-adrenoceptor agonists","volume":"84","author":"Schmitz W","year":"1989","journal-title":"Basic Res Cardiol"},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/clpt.1981.40","article-title":"Immediate cardiovascular responses to oral prazosin--effects of concurrent beta-blockers","volume":"29","author":"Elliott HL","year":"1981","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/0002-9149(79)90322-9","article-title":"Differences in hemodynamic effects of nitroprusside and prazosin in severe chronic congestive heart failure: evidence for a direct negative chronotropic effect of prazosin","volume":"44","author":"Packer M","year":"1979","journal-title":"Am J Cardiol"},{"issue":"10","key":"ref17","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1001\/archinte.1983.00350100203049","article-title":"Prazosin-induced bradycardia in acute treatment of hypertension","volume":"143","author":"Kobrin I","year":"1983","journal-title":"Arch Intern Med"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2165\/00002512-200219020-00004","article-title":"Tamsulosin: a review of its pharmacology and therapeutic efficacy in the management of lower urinary tract symptoms","volume":"19","author":"Dunn CJ","year":"2002","journal-title":"Drugs Aging"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2147\/ciia.2006.1.4.389","article-title":"Doxazosin in the treatment of benign prostatic hypertrophy: an update","volume":"1","author":"Wilt TJ","year":"2006","journal-title":"Clin Interv Aging"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0014-2999(78)90258-3","article-title":"Prazosin: differential affinities for two populations of alpha-noradrenergic receptor binding sites","volume":"50","author":"U'Prichard DC","year":"1978","journal-title":"Eur J Pharmacol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ejphar.2019.04.047","article-title":"Pharmacology of \u03b11-adrenoceptor subtypes","volume":"855","author":"Docherty JR","year":"2019","journal-title":"Eur J Pharmacol"},{"issue":"16","key":"ref22","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1111\/bph.15178","article-title":"ARRIVE 2.0 and the British Journal of Pharmacology: updated guidance for 2020","volume":"177","author":"Lilley E","year":"2020","journal-title":"Br J Pharmacol"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1161\/01.HYP.20.3.298","article-title":"Chronic inhibition of nitric oxide synthesis: a new model of arterial hypertension","volume":"20","author":"Ribeiro MO","year":"1992","journal-title":"Hypertension"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1476-5381.1990.tb14151.x","article-title":"Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo","volume":"101","author":"Rees DD","year":"1990","journal-title":"Br J Pharmacol"},{"issue":"3","key":"ref25","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00508293","article-title":"Presence and distribution of \u03b1-adrenoceptors in the heart of various mammalian species","volume":"302","author":"Wagner J","year":"1978","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1476-5381.1981.tb16791.x","article-title":"Alpha1-adrenoceptors can mediate chronotropic responses in the rat heart","volume":"73","author":"Flavahan NA","year":"1981","journal-title":"Br J Pharmacol"},{"issue":"2","key":"ref27","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0014-2999(87)90148-8","article-title":"Calcium antagonists inhibit positive chronotropic responses to alpha1-adrenoceptor activation in rat isolated atria","volume":"133","author":"Tung LH","year":"1987","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"ref28","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0021-5198(19)31692-0","article-title":"Evidence for the existence of alpha-adrenergic receptor in isolated rat atria","volume":"22","author":"Nakashima M","year":"1972","journal-title":"Jpn J Pharmacol"},{"issue":"3","key":"ref29","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/sj.bjp.0706048","article-title":"Selectivity of beta-adrenoceptor antagonists at the human beta1-, beta2- and beta3-adrenoceptors","volume":"144","author":"Baker JG","year":"2005","journal-title":"Br J Pharmacol"},{"issue":"3","key":"ref30","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/sj.bjp.0704855","article-title":"Pharmacological characterization of CGP 12177 at the human beta2-adrenoceptor","volume":"137","author":"Baker JG","year":"2002","journal-title":"Br J Pharmacol"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.cardiores.2003.09.020","article-title":"The alpha1B-adrenergic receptor decreases the inotropic response in the mouse Langendorff heart model","volume":"60","author":"Ross SA","year":"2003","journal-title":"Cardiovasc Res"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1476-5381.1974.tb09691.x","article-title":"Antagonism of the effect of isoprenaline on heart rate by pilocarpine","volume":"52","author":"Sadavongvivad C","year":"1974","journal-title":"Br J Pharmacol"},{"issue":"5","key":"ref33","doi-asserted-by":"crossref","first-page":"24C","DOI":"10.1016\/S0002-9149(88)80063-8","article-title":"Functional importance of beta1- and beta2-adrenoceptors in the human heart","volume":"62","author":"Brodde OE","year":"1988","journal-title":"Am J Cardiol"},{"issue":"5","key":"ref34","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1124\/mol.56.5.858","article-title":"Inverse agonism and neutral antagonism at alpha1A- and alpha1B-adrenergic receptor subtypes","volume":"56","author":"Rossier O","year":"1999","journal-title":"Mol Pharmacol"},{"issue":"8","key":"ref35","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1038\/sj.bjp.0703992","article-title":"Characterization of beta1-selectivity, adrenoceptor-G(s)-protein interaction and inverse agonism of nebivolol in human myocardium","volume":"132","author":"Maack C","year":"2001","journal-title":"Br J Pharmacol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0014-2999(03)02116-2","article-title":"Lack of inverse agonistic activity of nebivolol, its D- and L-enantiomers and of in vivo metabolized nebivolol in human myocardium","volume":"476(1-2)","author":"Bundkirchen A","year":"2003","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"ref37","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1254\/jphs.FP0060640","article-title":"Beta-blockers show inverse agonism to a novel constitutively active mutant of beta1-adrenoceptor","volume":"102","author":"Ahmed M","year":"2006","journal-title":"J Pharmacol Sci"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1597035","DOI":"10.3389\/fphar.2025.1597035","article-title":"Identification of adenylyl-cyclase modulators as receptors for 6-nitrodopamine in human induced pluripotent stem cell-derived cardiomyocytes and their relevance in heart inotropism","volume":"16","author":"Cipollone I","year":"2025","journal-title":"Front Pharmacol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"110589","DOI":"10.1016\/j.cellsig.2023.110589","article-title":"CAP1 (cyclase-associated protein 1) mediates the cyclic AMP signals that activate Rap1 in stimulating matrix adhesion of colon cancer cells","volume":"104","author":"Ramsey A","year":"2023","journal-title":"Cell Signal"},{"issue":"9","key":"ref40","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1007\/s11136-019-02205-w","article-title":"Health-related quality of life in adult males with lower urinary tract symptoms","volume":"28","author":"Kim SK","year":"2019","journal-title":"Qual Life Res"}],"container-title":["Brazilian Journal of Medical and Biological Research"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0100-879X2026000103867&tlng=en","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0100-879X2026000103867&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:00:21Z","timestamp":1791802821000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0100-879X2026000103867&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":40,"alternative-id":["S0100-879X2026000103867"],"URL":"https:\/\/doi.org\/10.1590\/1414-431x2026e15550","relation":{},"ISSN":["1414-431X","0100-879X"],"issn-type":[{"value":"1414-431X","type":"electronic"},{"value":"0100-879X","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"e15550"}}